Nitazoxanide versus rifaximin in preventing the recurrence of hepatic encephalopathy: A randomized double‐blind controlled trial
Author:
Affiliation:
1. Department of Clinical Pharmacy Faculty of Pharmacy Tanta University Tanta Egypt
2. Department of Tropical Medicine and Infectious Diseases Faculty of Medicine Tanta University Tanta Egypt
Publisher
Wiley
Subject
Hepatology,Surgery
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/jhbp.947
Reference39 articles.
1. Recent advances in hepatic encephalopathy
2. Pathophysiology of Hepatic Encephalopathy
3. Impact of Hepatic Encephalopathy in Cirrhosis on Quality-of-Life Issues
4. Hepatic Encephalopathy: Definition, Clinical Grading and Diagnostic Principles
5. Useful Tests for Hepatic Encephalopathy in Clinical Practice
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The antiprotozoal drug nitazoxanide improves experimental liver fibrosis in mice;Biochemical Pharmacology;2024-06
2. Future Therapies of Hepatic Encephalopathy;Clinics in Liver Disease;2024-05
3. Pharmacological efficacy and potential of the use of nitazoxanide, a thiazolide drug with a wide spectrum of action;Reviews on Clinical Pharmacology and Drug Therapy;2024-04-27
4. Prophylaxis of hepatic encephalopathy: current and future drug targets;Hepatology International;2024-03-16
5. Efficacy and Safety of Variable Treatment Options in the Prevention of Hepatic Encephalopathy: A Systematic Review and Network Meta-Analysis;Cureus;2024-01-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3